Investigating the effect of prednisolone
Phase 3
- Conditions
- Endometriosis.Endometriosis
- Registration Number
- IRCT20140111016161N10
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
confirm with trans vaginal / trans rectal ultra sonography
candidate for medical therapy
At least one year after surgical treatment
18 to 45 years
no desire to get pregnant in the last 3 months
Exclusion Criteria
Oligomenorrhea for three months or more
Primary need for endometriosis surgical treatment
Use of other hormonal agents during the study period
Abnormal findings in women's examination except endometriosis
Endometrioma above 5 cm
Contraindications for glucocorticoid use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dyspareunia. Timepoint: Before and 3 months after treatment starting. Method of measurement: Visual analogous scale.;Dysmenorrhea. Timepoint: Before and 3 months after treatment starting. Method of measurement: Visual analogous scale.;Dyschezia. Timepoint: Before and 3 months after treatment starting. Method of measurement: Visual analogous scale.
- Secondary Outcome Measures
Name Time Method